Pancratistatin
CAS: 96203-70-2
Ref. 3D-WDA20370
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
- (+)-Pancratistatin
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-Hexahydro-1,2,3,4,7-pentahydroxy[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
- NSC 349156
- Pancratistatine
- [1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, [1R-(1α,2β,3α,4α,4aα,11bβ)]-
- [1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R,2S,3S,4S,4aR,11bR)-
- [1,3]dioxolo[4,5-j]phenanthridine-1,2,3,4,6,7-hexol, 1,2,3,4,4a,11b-hexahydro-, (1R,2S,3S,4S,4aR,11bR)-
Pancratistatin is a naturally occurring compound with potent medicinal properties. It has been shown to induce apoptosis, or programmed cell death, in a variety of cancer cell lines, making it a promising candidate for the development of anticancer therapies. Pancratistatin works by inhibiting kinases and other proteins that are involved in tumor growth and survival. It has been found to be effective against leukemia cells and has also shown promise as an inhibitor of Chinese hamster ovary cells. Additionally, pancratistatin can be isolated from urine samples, making it a potentially valuable diagnostic tool for detecting cancer. With its powerful anticancer properties, pancratistatin represents a promising avenue for the development of new cancer treatments.
Chemical properties
Technical inquiry about: 3D-WDA20370 Pancratistatin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.